Crizanlizumab is an anti-P-selectin моноклональный антитело. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein лиганд 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle клетка disease.
Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.